TARA HALL: Open Payments
NPI 1700209236 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,101 in 103 payments from 17 companies in 2025. Trend: 2023 $7,214 · 2024 $13,432 · 2025 $11,101
Speaker / faculty: $6,975Food & beverage: $2,126Travel & lodging: $1,920Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $9,297 |
| GENZYME CORPORATION | 11 | $391 |
| UCB, Inc. | 19 | $327 |
| Novartis Pharmaceuticals Corporation | 9 | $248 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $164 |
| Regeneron Healthcare Solutions, Inc. | 6 | $162 |
| Janssen Biotech, Inc. | 2 | $98 |
| Incyte Corporation | 3 | $75 |
| LEO Pharma Inc. | 3 | $64 |
| Almirall LLC | 2 | $54 |
Products named: RINVOQ, SKYRIZI, DUPIXENT, Bimzelx, ILUMYA, TREMFYA, OPZELURA, COSENTYX.
Industry payments across TX — which companies pay providers there.
